Listing 1 - 10 of 31 | << page >> |
Sort by
|
Choose an application
The present book discusses three significant challenges of the built environment, namely regional and global climate change, vulnerability, and survivability under the changing climate. Synergies between local climate change, energy consumption of buildings and energy poverty, and health risks highlight the necessity to develop mitigation strategies to counterbalance overheating impacts. The studies presented here assess the underlying issues related to urban overheating. Further, the impacts of temperature extremes on the low-income population and increased morbidity and mortality have been discussed. The increasing intensity, duration, and frequency of heatwaves due to human-caused climate change is shown to affect underserved populations. Thus, housing policies on resident exposure to intra-urban heat have been assessed. Finally, opportunities to mitigate urban overheating have been proposed and discussed.
Mediterranean --- semi-arid --- drought --- standardized precipitation evapotranspiration index (SPEI) --- climate warming --- soil moisture --- urban heat islands --- environmental justice --- climate change --- redlining --- heatwave --- diurnal temperature range --- time-series --- relative risk --- health --- transpiration cooling --- coastal cities --- sap flow --- subtropical desert climate --- urban overheating --- cluster analysis --- air temperature --- wind speed and wind directions --- synoptic conditions --- urban heat island --- mitigation --- resilience --- survivability --- low-income population
Choose an application
The present book discusses three significant challenges of the built environment, namely regional and global climate change, vulnerability, and survivability under the changing climate. Synergies between local climate change, energy consumption of buildings and energy poverty, and health risks highlight the necessity to develop mitigation strategies to counterbalance overheating impacts. The studies presented here assess the underlying issues related to urban overheating. Further, the impacts of temperature extremes on the low-income population and increased morbidity and mortality have been discussed. The increasing intensity, duration, and frequency of heatwaves due to human-caused climate change is shown to affect underserved populations. Thus, housing policies on resident exposure to intra-urban heat have been assessed. Finally, opportunities to mitigate urban overheating have been proposed and discussed.
Research & information: general --- Mediterranean --- semi-arid --- drought --- standardized precipitation evapotranspiration index (SPEI) --- climate warming --- soil moisture --- urban heat islands --- environmental justice --- climate change --- redlining --- heatwave --- diurnal temperature range --- time-series --- relative risk --- health --- transpiration cooling --- coastal cities --- sap flow --- subtropical desert climate --- urban overheating --- cluster analysis --- air temperature --- wind speed and wind directions --- synoptic conditions --- urban heat island --- mitigation --- resilience --- survivability --- low-income population --- Mediterranean --- semi-arid --- drought --- standardized precipitation evapotranspiration index (SPEI) --- climate warming --- soil moisture --- urban heat islands --- environmental justice --- climate change --- redlining --- heatwave --- diurnal temperature range --- time-series --- relative risk --- health --- transpiration cooling --- coastal cities --- sap flow --- subtropical desert climate --- urban overheating --- cluster analysis --- air temperature --- wind speed and wind directions --- synoptic conditions --- urban heat island --- mitigation --- resilience --- survivability --- low-income population
Choose an application
Environmental Health. --- Risk. --- Genetic engineering --- Health risk assessment --- -Microbial genetics --- Microorganisms --- Genetics --- Microbiology --- Assessment, Health risk --- Health hazard appraisal --- Health hazard assessment --- Health risk appraisal --- HRA (Public health) --- Human risk assessment --- Medicine, Preventive --- Public health --- Risk assessment --- Environmental health --- Designed genetic change --- Engineering, Genetic --- Gene splicing --- Genetic intervention --- Genetic surgery --- Genetic recombination --- Biotechnology --- Transgenic organisms --- Relative Risk --- Relative Risks --- Risk, Relative --- Risks --- Risks, Relative --- Risk Reduction Behavior --- Harm Reduction --- Environmental Health Science --- Health, Environmental --- Environmental Health Sciences --- Environmental Healths --- Health Science, Environmental --- Health Sciences, Environmental --- Healths, Environmental --- Science, Environmental Health --- Sciences, Environmental Health --- Ecology --- Technique --- Biochemical engineering --- Molecular biology --- Microbial genetics --- Environmental Health --- Risk --- Incidence
Choose an application
The science of human genetics has advanced at an exponential pace since the double-helix structure of DNA was identified in 1953. Within only 25 years of that discovery, the first gene was sequenced. Subsequent efforts in the span of a few decades have brought advanced next-generation sequencing and new tools for genome editing, allowing scientists to write and rewrite the code of life. We are now realizing that genetics represents yet another system of information technology that follows Moore’s law, stating that computer processing power roughly doubles every two years. Importantly, with such rapid and sophisticated advancements, any tools or studies applicable to adult genetics can now also be applied to embryos.Genetic disorders affect 1% of live births and are responsible for 20% of pediatric hospitalizations and 20% of infant mortality. Many disorders are caused by recessive or X-linked genetic mutations carried by 85% of humans. Because assisted reproduction has armed us with technologies like in vitro fertilization that provide access to human embryos, we began to screen some genetic diseases simply by selecting sex. The first live births following preimplantation genetic testing (PGT) to identify sex in X-linked disease were reported by Alan Handyside in 1990. This groundbreaking work used the identification of male embryos and selective transfer of unaffected normal or carrier females as proof-of-concept to avoid genetic diseases, paving the way to extend the concept to PGT for monogenic diseases (PGT-M), including Mendelian single-gene defects (autosomal dominant/recessive, X-linked dominant/recessive), severe childhood lethality or early-onset disease, cancer predisposition, and HLA typing for histocompatible cord-blood stem cells’ transplantation. Later, we moved onto the identification and selection of euploid embryos by analysing all 23 pairs of chromosomes in 4–8 cells from the trophectoderm, called PGT for aneuploidy (PGT-A). PGT-A currently leverages next-generation sequencing technologies to uncover meiotic- and mitotic-origin aneuploidies affecting whole chromosomes, as well as duplications/deletions of small chromosome regions. A step forward was the use of structural chromosome rearrangements (PGT-SR) to identify Robertsonian and reciprocal translocations, inversions, and balanced vs. unbalanced rearrangements. Another advancement came with PGT for polygenic risk scoring (PGT-P). This technique takes us from learning how to read simple words to starting to understand poetry (i.e., evolving from PGT-M/A/SR to PGT-P for multifactorial, polygenic risk prediction). Moreover, we are moving from embryo selection to intervention because the genetic code is not only readable, but also re-writeable. Indeed, gene editing is now possible using tools like CRISPR/Cas9, which are applicable to all species, including human embryos.
extracellular vesicles --- exosomes --- microvesicles --- apoptotic bodies --- DNA --- preimplantation embryos --- murine blastocysts --- embryo --- uterus --- window of implantation --- PGT-A --- PGT-SR --- mosaicism --- embryo genetics --- chromosomal abnormality --- preimplantation genetic testing --- PGT-P --- polygenic risk scoring --- genomic index --- relative risk reduction --- combined preimplantation genetic testing --- Preimplantation genetic testing for monogenic disorders (PGT-M) --- Preimplantation genetic testing for aneuploidy assessment (PGT-A) --- Autosomal dominant polycystic kidney disease (ADPKD) --- male infertility --- advanced maternal age --- aneuploidy --- NGS --- segmental --- translocations --- monogenic disease --- multiplex PCR --- SNP array --- genome editing --- genetic diseases --- embryos --- vitrification --- ovarian response --- female age --- genetic testing --- reproductive health --- next-generation sequencing --- whole exome sequencing --- perinatal care --- infertility --- aneuploidies --- polygenic disease --- blastocyst --- endometrium --- implantation
Choose an application
Toxicology --- Toxicity testing --- Environmental health --- Toxicité --- Hygiène du milieu --- Research --- Evaluation --- Government policy --- Decision making --- Tests --- Risk. --- Carcinogens --- Neoplasms --- Environmental Health. --- Environmental Exposure. --- Health Policy. --- Probability. --- -Environmental health --- -Toxicity testing --- -Probabilities --- National Health Policy --- Health Policies --- Health Policies, National --- Health Policy, National --- National Health Policies --- Policies, Health --- Policies, National Health --- Policy, Health --- Policy, National Health --- Policy Making --- Environmental Health Science --- Health, Environmental --- Environmental Health Sciences --- Environmental Healths --- Health Science, Environmental --- Health Sciences, Environmental --- Healths, Environmental --- Science, Environmental Health --- Sciences, Environmental Health --- Ecology --- Environmental quality --- Health --- Health ecology --- Public health --- Environmental engineering --- Health risk assessment --- Chemicals --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Toxicological testing --- Toxicology testing --- Toxicology, Experimental --- Relative Risk --- Relative Risks --- Risk, Relative --- Risks --- Risks, Relative --- Risk Reduction Behavior --- Harm Reduction --- Exposure, Environmental --- Environmental Exposures --- Exposures, Environmental --- Sentinel Species --- toxicity. --- chemically induced. --- -Decision making --- Health aspects --- Environmental aspects --- Testing --- Probabilities --- Toxicity testing. --- Evaluation. --- Decision making. --- Research. --- -toxicity. --- Toxicité --- Hygiène du milieu --- Healthcare Policy --- Healthcare Policies --- Policy, Healthcare --- Incidence --- Risk --- Environmental Health --- Environmental Exposure --- Health Policy --- Probability --- -Chemicals --- toxicity --- chemically induced --- -Relative Risk --- Health Care Policies --- Care Policies, Health --- Health Care Policy --- Policies, Health Care --- Policies, Healthcare --- Policy, Health Care --- -Environmental quality --- -toxicity
Choose an application
The science of human genetics has advanced at an exponential pace since the double-helix structure of DNA was identified in 1953. Within only 25 years of that discovery, the first gene was sequenced. Subsequent efforts in the span of a few decades have brought advanced next-generation sequencing and new tools for genome editing, allowing scientists to write and rewrite the code of life. We are now realizing that genetics represents yet another system of information technology that follows Moore’s law, stating that computer processing power roughly doubles every two years. Importantly, with such rapid and sophisticated advancements, any tools or studies applicable to adult genetics can now also be applied to embryos.Genetic disorders affect 1% of live births and are responsible for 20% of pediatric hospitalizations and 20% of infant mortality. Many disorders are caused by recessive or X-linked genetic mutations carried by 85% of humans. Because assisted reproduction has armed us with technologies like in vitro fertilization that provide access to human embryos, we began to screen some genetic diseases simply by selecting sex. The first live births following preimplantation genetic testing (PGT) to identify sex in X-linked disease were reported by Alan Handyside in 1990. This groundbreaking work used the identification of male embryos and selective transfer of unaffected normal or carrier females as proof-of-concept to avoid genetic diseases, paving the way to extend the concept to PGT for monogenic diseases (PGT-M), including Mendelian single-gene defects (autosomal dominant/recessive, X-linked dominant/recessive), severe childhood lethality or early-onset disease, cancer predisposition, and HLA typing for histocompatible cord-blood stem cells’ transplantation. Later, we moved onto the identification and selection of euploid embryos by analysing all 23 pairs of chromosomes in 4–8 cells from the trophectoderm, called PGT for aneuploidy (PGT-A). PGT-A currently leverages next-generation sequencing technologies to uncover meiotic- and mitotic-origin aneuploidies affecting whole chromosomes, as well as duplications/deletions of small chromosome regions. A step forward was the use of structural chromosome rearrangements (PGT-SR) to identify Robertsonian and reciprocal translocations, inversions, and balanced vs. unbalanced rearrangements. Another advancement came with PGT for polygenic risk scoring (PGT-P). This technique takes us from learning how to read simple words to starting to understand poetry (i.e., evolving from PGT-M/A/SR to PGT-P for multifactorial, polygenic risk prediction). Moreover, we are moving from embryo selection to intervention because the genetic code is not only readable, but also re-writeable. Indeed, gene editing is now possible using tools like CRISPR/Cas9, which are applicable to all species, including human embryos.
Research & information: general --- extracellular vesicles --- exosomes --- microvesicles --- apoptotic bodies --- DNA --- preimplantation embryos --- murine blastocysts --- embryo --- uterus --- window of implantation --- PGT-A --- PGT-SR --- mosaicism --- embryo genetics --- chromosomal abnormality --- preimplantation genetic testing --- PGT-P --- polygenic risk scoring --- genomic index --- relative risk reduction --- combined preimplantation genetic testing --- Preimplantation genetic testing for monogenic disorders (PGT-M) --- Preimplantation genetic testing for aneuploidy assessment (PGT-A) --- Autosomal dominant polycystic kidney disease (ADPKD) --- male infertility --- advanced maternal age --- aneuploidy --- NGS --- segmental --- translocations --- monogenic disease --- multiplex PCR --- SNP array --- genome editing --- genetic diseases --- embryos --- vitrification --- ovarian response --- female age --- genetic testing --- reproductive health --- next-generation sequencing --- whole exome sequencing --- perinatal care --- infertility --- aneuploidies --- polygenic disease --- blastocyst --- endometrium --- implantation --- extracellular vesicles --- exosomes --- microvesicles --- apoptotic bodies --- DNA --- preimplantation embryos --- murine blastocysts --- embryo --- uterus --- window of implantation --- PGT-A --- PGT-SR --- mosaicism --- embryo genetics --- chromosomal abnormality --- preimplantation genetic testing --- PGT-P --- polygenic risk scoring --- genomic index --- relative risk reduction --- combined preimplantation genetic testing --- Preimplantation genetic testing for monogenic disorders (PGT-M) --- Preimplantation genetic testing for aneuploidy assessment (PGT-A) --- Autosomal dominant polycystic kidney disease (ADPKD) --- male infertility --- advanced maternal age --- aneuploidy --- NGS --- segmental --- translocations --- monogenic disease --- multiplex PCR --- SNP array --- genome editing --- genetic diseases --- embryos --- vitrification --- ovarian response --- female age --- genetic testing --- reproductive health --- next-generation sequencing --- whole exome sequencing --- perinatal care --- infertility --- aneuploidies --- polygenic disease --- blastocyst --- endometrium --- implantation
Choose an application
Assessment [Health risk ] --- Estimation des risques de santé --- Gezondheid [Schatting van het risico voor de ] --- Gezondheidsrisico [Schatting van het ] --- HRA (Public health) --- Health hazard appraisal --- Health hazard assessment --- Health risk appraisal --- Health risk assessment --- Human risk assessment --- Risico voor de gezondheid [Schatting van het ] --- Schatting van het risico voor de gezondheid --- Probability. --- Radiation Effects. --- Radioactive Pollutants --- Radon --- Risk. --- Alpha rays --- -Health risk assessment --- Radioisotopes in the body --- -Radon --- -Emanation (Radioactive substances) --- Emanon --- Niton --- Radium emanation --- Gases, Rare --- Radioactive substances --- Radiobiology --- Radioisotopes --- Assessment, Health risk --- Medicine, Preventive --- Public health --- Risk assessment --- Environmental health --- Alpha particles --- Neutrons --- Protons --- Radiation --- Delta rays --- Relative Risk --- Relative Risks --- Risk, Relative --- Risks --- Risks, Relative --- Risk Reduction Behavior --- Harm Reduction --- Effects, Radiation --- Effect, Radiation --- Radiation Effect --- Radiation Genetics --- Radiation Tolerance --- Probabilities --- adverse effects. --- Health aspects --- Physiological effect --- -adverse effects. --- Probability --- Radiation Effects --- Risk --- Emanation (Radioactive substances) --- adverse effects --- Incidence
Choose an application
Hygiene. Public health. Protection --- Choice Behavior --- Decision Making --- Probability --- Health risk assessment --- Medicine --- Risques pour la santé --- Médecine --- Decision making --- Evaluation --- Prise de décision --- Environmental Health. --- Health Behavior. --- Life Style. --- Risk. --- -Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Assessment, Health risk --- Health hazard appraisal --- Health hazard assessment --- Health risk appraisal --- HRA (Public health) --- Human risk assessment --- Medicine, Preventive --- Public health --- Risk assessment --- Environmental health --- Relative Risk --- Relative Risks --- Risk, Relative --- Risks --- Risks, Relative --- Risk Reduction Behavior --- Harm Reduction --- Life Style Induced Illness --- Lifestyle --- Life Styles --- Lifestyles --- Quality of Life --- Social Environment --- Behavior, Health --- Behaviors, Health --- Health Behaviors --- Health Promotion --- Life Style --- Environmental Health Science --- Health, Environmental --- Environmental Health Sciences --- Environmental Healths --- Health Science, Environmental --- Health Sciences, Environmental --- Healths, Environmental --- Science, Environmental Health --- Sciences, Environmental Health --- Ecology --- Healthy Lifestyle --- -Decision making --- Risques pour la santé --- Médecine --- Prise de décision --- -Assessment, Health risk --- Clinical sciences --- Choice Behavior. --- Decision Making. --- Probability. --- Health-Related Behavior --- Behavior, Health-Related --- Behaviors, Health-Related --- Health Related Behavior --- Health-Related Behaviors --- Health Workforce --- Incidence --- Lifestyle Factors --- Factor, Lifestyle --- Lifestyle Factor --- Environmental Health --- Health Behavior --- Risk --- -Health Workforce
Choose an application
Actuarial mathematics --- Carcinogenicity testing --- Health risk assessment --- Cancérogénicité --- Risques pour la santé --- Decision making --- Prise de décision --- Evaluation --- Carcinogens --- Decision Making. --- Mutagenicity Tests. --- Risk. --- -Health risk assessment --- -Assessment, Health risk --- Health hazard appraisal --- Health hazard assessment --- Health risk appraisal --- HRA (Public health) --- Human risk assessment --- Medicine, Preventive --- Public health --- Risk assessment --- Environmental health --- Carcinogenesis --- Carcinogenic activity testing --- Testing for carcinogenicity --- Chronic toxicity testing --- Oncology, Experimental --- Relative Risk --- Relative Risks --- Risk, Relative --- Risks --- Risks, Relative --- Risk Reduction Behavior --- Harm Reduction --- Tests, Genetic Toxicity --- Toxicity Tests, Genetic --- Genetic Toxicity Tests --- Genotoxicity Tests --- Mutagen Screening --- Genetic Toxicity Test --- Genotoxicity Test --- Mutagen Screenings --- Mutagenicity Test --- Screening, Mutagen --- Screenings, Mutagen --- Test, Genotoxicity --- Tests, Genotoxicity --- Toxicity Test, Genetic --- Carcinogenicity Tests --- Decision Making, Shared --- Decision Makings, Shared --- Making, Shared Decision --- Makings, Shared Decision --- Shared Decision Making --- Shared Decision Makings --- Problem Solving --- toxicity. --- Testing --- -toxicity. --- Cancérogénicité --- Risques pour la santé --- Prise de décision --- Decision Making --- Mutagenicity Tests --- Risk --- Assessment, Health risk --- toxicity --- Citizen Science --- Incidence --- Credit Assignment --- Assignment, Credit --- Assignments, Credit --- Credit Assignments
Choose an application
Activités de recherche --- Bestraling--Dosering --- Bestralingsletsels --- Bestralingsziekte --- Dosimetry --- Lésions par irradiation --- Maladie des rayons --- Onderzoek --- Programmes de recherche --- Projets de recherche --- Radiation disease --- Radiation dosimetry --- Radiation injuries --- Radiation monitoring --- Radiation sickness --- Radiation syndrome --- Radiation--Dosage--Measurement --- Radiations--Dosage --- Radioactieve bestraling [Letsels door ] --- Recherche --- Recherche fondamentale --- Recherche pure --- Recherche scientifique --- Recherche--Programmes --- Recherche--Projets --- Research --- Risico --- Risk --- Risque --- Science research --- Science--Research --- Sciences--Recherche --- Scientific research --- Wetenschappelijk onderzoek --- Risk. --- Radiation Protection. --- Research. --- Radiation Injuries. --- Radiation Dosage. --- Dosage, Radiation --- Gray Units --- Gy Radiation --- Sv Radiation Dose Equivalent --- Sievert Units --- Dosages, Radiation --- Radiation Dosages --- Units, Gray --- Units, Sievert --- Injuries, Radiation --- Radiation Sickness --- Radiation Syndrome --- Injury, Radiation --- Radiation Injury --- Radiation Sicknesses --- Radiation Syndromes --- Sickness, Radiation --- Sicknesses, Radiation --- Syndrome, Radiation --- Syndromes, Radiation --- Radioactive Hazard Release --- Laboratory Research --- Research Activities --- Research and Development --- Research Priorities --- Activities, Research --- Activity, Research --- Development and Research --- Priorities, Research --- Priority, Research --- Research Activity --- Research Priority --- Research, Laboratory --- Ethics, Research --- Protection, Radiation --- Protections, Radiation --- Radiation Protections --- Health Physics --- Nuclear Energy --- Radiation Injuries --- Relative Risk --- Relative Risks --- Risk, Relative --- Risks --- Risks, Relative --- Risk Reduction Behavior --- Harm Reduction --- Ionizing radiation --- Radiation Dosage --- Radiation Protection --- Radiation --- Nuclear counters --- Health aspects --- Safety measures --- Dosage --- Measurement --- Atomic Bomb Survivors --- Incidence
Listing 1 - 10 of 31 | << page >> |
Sort by
|